LONDON BROKER RATINGS: Oddo BHF cuts Wizz Air and Ryanair
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More
| Price | 13,956.00p on 06-02-2026 at 14:53:43 |
|---|---|
| Change | -24.00p -0.17% |
| Buy | 13,958.00p |
| Sell | 13,956.00p |
| Last Trade: | Sell 11.00 at 13,960.00p |
| Day's Volume: | 641,218 |
| Last Close: | 13,980.00p |
| Open: | 13,884.00p |
| ISIN: | GB0009895292 |
| Day's Range | 13,846.00p - 14,060.00p |
| 52wk Range: | 9,574.00p - 14,408.00p |
| Market Capitalisation: | £216.36b |
| VWAP: | 13,984.3631p |
| Shares in Issue: | 1.55b |
Astrazeneca (AZN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 11 | 13,960.00p | Automatic Execution |
14:53:42 - 06-Feb-26 |
| Sell* | 32 | 13,960.00p | Automatic Execution |
14:53:42 - 06-Feb-26 |
| Sell* | 1 | 13,960.00p | Automatic Execution |
14:53:42 - 06-Feb-26 |
| Sell* | 49 | 13,960.00p | Automatic Execution |
14:53:42 - 06-Feb-26 |
| Sell* | 56 | 13,964.00p | Automatic Execution |
14:53:42 - 06-Feb-26 |
| Sell* | 21 | 13,964.00p | Automatic Execution |
14:53:42 - 06-Feb-26 |
| Sell* | 10 | 13,964.00p | Automatic Execution |
14:53:39 - 06-Feb-26 |
| Sell* | 30 | 13,966.00p | Automatic Execution |
14:53:39 - 06-Feb-26 |
| Sell* | 24 | 13,966.00p | Automatic Execution |
14:53:39 - 06-Feb-26 |
| Sell* | 25 | 13,966.00p | Automatic Execution |
14:53:39 - 06-Feb-26 |
Astrazeneca (AZN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Feb 2026 7:00 am | RNS | Update on Saphnelo subcutaneous administration |
| 2nd Feb 2026 3:00 pm | RNS | Total Voting Rights |
| 2nd Feb 2026 7:05 am | RNS | Imfinzi recommended in EU for early gastric cancer |
| 2nd Feb 2026 7:00 am | RNS | AstraZeneca begins trading on NYSE |
| 30th Jan 2026 7:00 am | RNS | AstraZeneca agrees obesity and T2D deal with CSPC |
| 29th Jan 2026 9:51 am | RNS | AstraZeneca invests $15bn in China through 2030 |
| 20th Jan 2026 7:00 am | RNS | AstraZeneca to complete direct listing on NYSE |
| 8th Jan 2026 7:00 am | RNS | AZN new Head of Investor Relations Joris Silon |
| 2nd Jan 2026 3:00 pm | RNS | Total Voting Rights |
| 22nd Dec 2025 11:00 am | RNS | Director/PDMR Shareholding |